Introduction
============

The imaging modality of choice for prenatal diagnosis of congenital heart disease (CHD) is due to its ease of use, high availability, and high diagnostic accuracy fetal echocardiography.^[@B1],[@B2]^ However, fetal echocardiography is occasionally limited by the acoustic window, fetal position, maternal adipose tissue, gestational age, abdominal wall scars, and the level of training of the operator.^[@B3],[@B4]^

Prenatal detection of CHD using echocardiography varies widely from 13% to 82%.^[@B5]^ Moreover, discordances of up to 29% between pre- and post-natal diagnoses of CHD and a limited ability to measure blood flow using echocardiography encourages the development of new techniques to improve prenatal cardiovascular imaging.^[@B6]^

Fetal MRI is increasingly used as a second-line imaging tool for prenatal evaluation of the fetal brain^[@B7]^ and other organs including the fetal heart.^[@B3]^ Fetal cardiac MRI may provide a valuable adjunct to fetal echocardiography as it provides the ability to image the fetal heart with excellent tissue contrast in arbitrary planes independent of the above-mentioned limitations of fetal echocardiography.^[@B8]^ Fetal cardiovascular magnetic resonance (CMR) may be especially helpful for the detection of duct-dependent lesions, such as coarctation of the aorta^[@B9]^ and to recognize CHD in late gestation.^[@B3]^ One of the main challenges for high-quality fetal cardiac images using conventional cine reconstruction methods is accurate synchronization of the cardiac cycle with the MRI data acquisition,^[@B10]^ usually achieved using the spatial information of an electrocardiogram (ECG).^[@B11]^ However, the ECG cannot be applied for fetal cardiac MRI and several methods were developed to assign the acquired image data to the correct cardiac cycle using retrospective image reconstruction based on post-processing techniques.^[@B12]--[@B14]^ Although post-processing methods are capable of producing a good image quality, their time-consuming image reconstruction in combination with fetal movement represents a crucial disadvantage and prevents the possibility to adapt imaging planes in real time.

In order to employ clinically proven cardiac imaging methods in conjunction with an immediate image reconstruction, a direct gating method is necessary. A well-established technique to acquire the fetal heart rate is based on Doppler ultrasound (DUS).^[@B15]^ Doppler ultrasound is capable of recording the fetal heart rate in real-time and is in theory not influenced by the electromagnetic field of the MRI.^[@B16]--[@B18]^ Thus, DUS represents an ideal method to synchronize the MRI data acquisition with the fetal cardiac cycle. The method was applied to gate the image acquisition for adult cardiac MRI^[@B19],[@B20]^ and for fetal MRI in a sheep model^[@B21]^ using a standard cardiotocograph (CTG). However, using a commercially available CTG is accompanied by two major drawbacks. First, the software is not designed to detect every single heartbeat of the fetus, which is implicitly necessary for cardiac cine MRI. Second, the hardware is normally not designed for the hazardous MRI environment, e.g., regarding safety concerns by placing the transducer and connecting cable directly under the Receive (RX) coil.

The purpose of this work was to develop and evaluate an MRI conditional and portable DUS device for 1.5T and 3T that can be operated within the MRI room during image acquisition with regard on compatibility, functionality, and reliability in order to enable fetal cardiac gating for cine MRI.

Materials and Methods
=====================

Study population
----------------

The study population consisted of 15 healthy pregnant volunteers (30--37 weeks gestation) participating in the validation study outside the MRI and two healthy pregnant volunteers for the MRI measurements (34 and 36 weeks of gestation). The fetuses of the pregnant volunteers had no diagnosis or suspicion of congenital cardiovascular disease. The study was approved by the local ethics committee. Informed written consent from each volunteer was obtained in advance of the study.

DUS gating device
-----------------

The DUS gating setup is schematically shown in [Fig. 1](#F1){ref-type="fig"}. The electronics of the DUS device was a custom build and was placed inside the MRI room during data acquisition. The DUS device was battery powered by lithium battery of 10.4 V with dimensions of 20 × 10 × 15 cm^3^. Ultrasound pulses of 1 MHz were transmitted with a repetition frequency of 3.2 kHz resulting in an acoustic intensity of 4.6 mW/cm^2^ at the ultrasound transducer (HP 15245A; Hewlett Packard, Palo Alto, CA, USA). All components of the transducer were replaced by non-magnetic materials or materials with a low magnetic permeability. The piezoelectric elements were made of non-magnetic lead zirconate titanate with a diameter of 1 cm. The connection between the transducer and the DUS electronic was realized using a 7 m long cable shielded with aluminum. In order to ensure patient safety and sufficient MRI compatibility, the cable was decoupled with respect to the B~1~ field using cable traps. As the DUS device was used at 1.5T and 3T, two different cable setups were used. Four cable traps were required for each cable with a distance of 30 cm for 1.5T and a distance of 20 cm at 3T.

A solenoid balun was used as cable trap for 64 MHz as described by Peterson et al.^[@B22]^ and a floating shield current suppression trap was used for 128 MHz following the method of Seeber et al.^[@B23]^ Each trap was tuned manually to the corresponding Larmor frequency using a network analyzer with a 50 Ω termination.

To create a gating signal, the received ultrasound signal was amplified in a first stage and demodulated and filtered in a second stage ([Fig. 1](#F1){ref-type="fig"}) with a pass band of 0--400 Hz. The main components in the DUS signal are the heart wall motion and a fraction of the blood flow. The heart wall motion is more prominent than the blood flow^[@B24]^ and consists mainly of the atrial and ventricular contraction.^[@B25]^ The heart wall motion was chosen as a signal source for the Doppler signal as it directly reflects the moments in the time needed to synchronize the MRI. In order to exclude the blood flow, the Doppler signal was low-pass filtered with a cut-off frequency of 100 Hz. Subsequently, the envelope of the DUS signal (0--10 Hz) was used for further peak detection analysis implemented on a microcontroller ([Fig. 1](#F1){ref-type="fig"}). The signal was evaluated in two different paths. A threshold was calculated based on the envelope of the DUS signal in order to exclude peaks related to myocardial motion during diastole. In parallel, an autocorrelation of the first 1250 ms of the DUS signal was performed to estimate the RR interval. In the following step, a shiftable cover window was calculated based on the estimated beat-to-beat (RR) interval and previously detected gating time points in order to restrict the peak detection to a time point where the next gating is expected ([Fig. 1](#F1){ref-type="fig"}). Following, the peak detection was only performed inside the cover window and to peaks belonging to minima of the DUS signal. Based on the results of the last digital processing step, standard transistor--transistor logic (TTL) square wave gating signals were transferred to the MRI using a coaxial cable.

MRI safety
----------

As long as conducting wires with a cable shield were used for signal transmission, the used transmission line can couple significantly with the transmitted energy of the radiofrequency (RF) transmit (TX) coil, leading to potentially large common mode currents associated with possible tissue burns along the cable.^[@B26]^ Therefore, the cables were tested for MRI safety compliance. The ability to attenuate common mode currents and to decouple the cable from the RF transmit field was evaluated using the 2-port transmission characteristics of S21 utilizing a network analyser (S332E Site Masters; Anritsu Corporation, Kanagawa, Japan) and current probes.

Moreover, the effect of the cable traps on the shield currents was tested using the method of Seeber et al.,^[@B23]^ comparing the image homogeneity of large FOV (500 mm) coronal gradient echo images with and without the cable and transducer. Coronal views were chosen to show that there were no signal alterations along the cable due to common mode currents. For the measurement, two phantom bottles were placed next to each other with the cable in between. If common mode currents are present, image homogeneity will be affected by the shield currents leading to image distortions. Hence, the signal intensity within the phantom bottles was compared between images with and without transmission line. In addition, B~1~ flip angle maps were acquired using a large water phantom filled with tissue simulating liquid in order to evaluate possible B~1~ distortions due to inductive coupling with the transmission line.

Evaluation using a fetal cardiac phantom
----------------------------------------

The DUS device was first evaluated using a self-manufactured fetal cardiac phantom based on a simplified biventricular design ([Fig. 2](#F2){ref-type="fig"}). The anatomical dimensions were based on literature values of a 36-week-old fetus with a right and left ventricular diameter of 215 mm and height of 590 mm.^[@B27]^ A two-chamber structure polyamide mold was designed using a CAD software (Inventor; Autodesk Inc., San Rafael, CA, USA) and subsequently 3-D printed (Ultimaker, Geldermalsen, The Netherlands). For fabrication of the phantom, a room temperature vulcanization silicone rubber (TFC Silikon; Troll Factory Rainer Habekost e.K., Germany) was poured inside the mold with a cure time of 4 h. The heart was mounted in a sealed water container and connected to a hydraulic pumping system. The pulsatile flow was generated by an hydro-motor (Pentair / SHURFLO, Costa Mesa, CA, US) connected to two solenoid valves (NC 3/2; M&M International, Milano, Italy), controlled by a micro-controller (UNO AG; Arduino, Italy) that simulates the cardiac heart cycle.

In order to test the DUS device inside the MRI, the cardiac phantom was placed inside the 1.5T and 3T system and was connected to the pumping system that was placed outside of the MRI room. The DUS sensor was placed on the side of the water container to record the movement of the fetal heart phantom. The gating signal of the DUS device was subsequently transferred to the physiologic unit of the MRI to test the ability of the DUS device to gate the heart movement using a steady-state free precession (SSFP) cine sequence at 1.5T and 3T. The frequency of the heart cycle was varied between 75 and 200 BPM in 20 steps and compared to the detected gating signal of the DUS device. Imaging parameters for 1.5T were: pixel spacing = 1.48 × 1.48 mm^2^, slice thickness = 4 mm, TR = 3.1 ms, TE = 1.5 ms, flip-angle = 60°, parallel acquisition technique = sensitivity encoding (SENSE) (acceleration factor = 2), matrix = 256 × 256, phases = 30, slices = 20, temporal resolution = 30 ms, and for 3T: pixel spacing = 0.99 × 0.99 mm^2^ matrix: 352 × 352, TR = 4.8 ms, TE = 1.4 ms, flip-angle = 45°, turbo factor = 13, SENSE = 2, slices = 8, slice thickness = 4 mm.

Verification of the DUS algorithm
---------------------------------

The proposed algorithm to detect the fetal heart motion was evaluated prior to MRI measurements in the department of gynecology outside the MRI at 15 pregnant volunteers at 29--39 weeks of gestation. The transducer of the DUS device was placed above the fetal heart on the abdomen of the volunteer and was fixated using a belt after a stable heart signal was found. For each volunteer, 2 min of Doppler signal and corresponding generated gating signal were recorded using an internal secure digital (SD) card. The stored Doppler signal was evaluated manually in order to validate the generated gating signals of the DUS device. The peaks were subsequently selected based on a visual assessment by two independent observers and compared to the gating signal generated by the DUS device.

Fetal MRI
---------

To evaluate the DUS gating device, one volunteer (34 gestational weeks) was examined at 1.5T (Achieva; Philips Medical Systems Best, the Netherlands) and one volunteer (36 gestational weeks) at 3T (Ingenia; Philips Medical Systems). The developed DUS device was approved by the local ethics committee. For fetal cardiac cine imaging, gating signals were acquired with the MRI-conditional DUS device and transferred to the physiologic unit of the MRI scanner in real-time. For each scan, the transducer was placed above the fetal heart and fixated using a belt. Retrospectively gated cine balanced SSFP sequences were acquired in four-chamber view for 1.5T (pixel spacing = 1.0 × 1.0 mm^2^, slice thickness = 5 mm, TR = 5.0 ms, TE = 1.6 ms, flip-angle = 60°, parallel acquisition technique = SENSE (acceleration factor = 2), matrix = 288 × 288, phases = 20, slices = 1, temporal resolution = 30 ms, acquisition duration = 9 s) and 3T (pixel spacing = 1.0 × 1.0 mm^2^, slice thickness = 5 mm, TR = 5.0 ms, TE = 1.6 ms, flip-angle = 60°, parallel acquisition technique = SENSE (acceleration factor = 2), matrix = 288 × 288, phases = 20, slices = 1, temporal resolution = 30 ms, acquisition duration = 9 s). Gating signals were stored during data acquisition and analyzed with respect to gating quality and variability. Fetal cardiac cine images were analyzed in terms of endocardial blurring.

Results
=======

MRI safety evaluation
---------------------

The ability to attenuate common mode currents on the cable shield was measured for each cable trap at the desired Larmor frequency of 64 and 128 MHz ([Table 1](#T1){ref-type="table"}). Each cable trap fulfilled the requirement of at least 20 dB attenuation. Gradient echo images with the transducer and transmission line between the phantoms are shown in [Fig. 3](#F3){ref-type="fig"}. B~1~ image homogeneity showed no visible distortion within the whole phantom. Measurements of the mean flip angle showed a mean difference between images with and without transmission line of 4.9 ± 18% at 3T and of 6.5 ± 1.2% at 1.5T ([Fig. 3](#F3){ref-type="fig"}). It can be seen that the transmission line is not affecting the image homogeneity and signal intensity, indicating a successful suppression of shield currents. The maximum difference in signal intensity of the gradient echo images between the two phantoms with and without transmission line was 4% for 1.5T and 6% for 3T.

Evaluation using a fetal cardiac phantom
----------------------------------------

The fetal cardiac phantom was successfully evaluated at 1.5T and 3T without image artifacts ([Fig. 4](#F4){ref-type="fig"}). The contraction of the fetal heart phantom could be clearly visualized from systole to diastole at 1.5T and 3T without motion artifacts with a good delineation of the simulated ventricular walls ([Fig. 4](#F4){ref-type="fig"}). The trigger generated by the DUS device during MRI was derived without distortions due to electromagnetic interferences and showed a high correlation to the simultaneously acquired control signal of *R* = 0.99 for 1.5T and *R* = 0.99 for 3T, respectively. A total of 2924 heart cycles were acquired at 1.5T and 2789 heart cycles at 3T, whereas the DUS device was able to detect all generated heart cycles at 1.5T (100%), as well as at 3T (100%) ([Table 2](#T2){ref-type="table"}). The mean difference in RR cycle length between the control signal generated by the phantom and the DUS gating signal was 5.5 ± 4.5 ms for 1.5T and 5.6 ± 4.6 ms for 3T, respectively. The control signal showed a variability of 0.1 ± 0.01 ms. The detected heart cycle by the DUS device showed an increased variability of 6.4 ± 2.1 ms for 1.5T and 6.5 ± 2.9 ms for 3T. The mean correlation for the combined data of detected trigger time points of 1.5T and 3T measurements in comparison to the control signal generated by the heart phantom was *R* = 0.99 with a mean offset of 4.1 ± 2.3 ms ([Fig. 5](#F5){ref-type="fig"}).

Verification of the DUS algorithm
---------------------------------

Mean results for all volunteers are shown in [Table 2](#T2){ref-type="table"}. A total of 3876 heart cycles were evaluated whereas the DUS device detected 3860 heart cycles with a sensitivity compared to the manually selected heart cycles of 99%. The mean RR length of manually selected heart cycles was 434 ± 32 ms and the mean RR length of detected trigger time points by the DUS device was 434 ± 31 ms. The variability of the gating signal and the manually selected heart cycle was 22.0 ± 7.6 ms and 22.0 ± 7.6 ms, respectively. The correlation between the DUS gating signal and the manually selected heart cycles was *R* = 0.99 with a mean difference of 0.1 ± 11 ms ([Fig. 5](#F5){ref-type="fig"}).

Fetal MRI
---------

Fetal cardiac MRI was possible at 1.5T and 3T using the external gating signal provided by the DUS device. The DUS signal was stable throughout all measurements and no repositioning was necessary whereas each examination was completed after approximately 35 min. The DUS signals recorded during MR cine imaging were not influenced by electromagnetic interferences and showed no artifacts as exemplarily shown in [Fig. 6](#F6){ref-type="fig"} for 1.5T. For cine imaging at a total of 37 RR intervals were acquired at 1.5T and 65 intervals at 3T with a mean RR length of 395 ± 22 ms and 475 ± 34 ms, respectively. A total of four intervals (1.5T) and one interval (3T) were excluded by the MRI scanner due to arrhythmia, resulting in a sensitivity of 90% and 99%, respectively. Retrospectively gated cardiac cine images of the fetus are shown in [Fig. 7](#F7){ref-type="fig"} for 1.5T and 3T with corresponding M-mode projection over one entire cardiac cycle calculated in a mid-ventricular position in the four-chamber view. Indicating correct gating, the contraction of the heart was clearly visible from the apex to the base, whereas the atrial septum could be clearly depicted without motion artifacts.

Discussion
==========

An MRI conditional and portable DUS device was successfully developed and evaluated for 1.5T and 3T in terms of MR compatibility, functionality, and reliability. It was shown that the DUS device is MR conditional and can be operated within the MRI without being influenced by electromagnetic interferences. The feasibility to detect the fetal heart motion and to generate a trigger signal was confirmed in a validation study of fetuses outside the MRI room. In addition, the device was successfully applied in a preliminary test for fetal cardiac cine imaging at 1.5T and 3T without motion artifacts and good delineation of ventricular motion.

One prerequisite for cardiac cine MRI is accurate synchronization with the cardiac cycle.^[@B11]^ As the heart cycle and hence the gating signal of the fetal heart cannot be derived within the MRI environment employing the routinely used electrocardiogram,^[@B14]^ a different technique was developed in this work based on DUS. The DUS is routinely used in obstetrics for fetal heart rate monitoring^[@B28],[@B29]^ and is an ideal method to derive the fetal heart rate as the method is theoretically not influenced by the electromagnetic field of the MRI^[@B17],[@B18],[@B30]^ and hence promises a stable gating signal. Although ultrasound is not interacting with electromagnetic fields, a cable and piezoelectric elements are still necessary for signal transmission, which can couple significantly with the RF transmit field of the MRI. As the used cable is longer than the free-space wavelength, common mode signals cannot be ignored as local electric field amplifications can lead to a potentially large temperature increase along the cable.^[@B31]--[@B33]^ This circumstance significantly influences patients' safety and MRI signal reception. In order to reduce the risk of an RF burn of the patient and to reduce excessive noise in the MRI signal, cable traps^[@B22],[@B23],[@B34]^ were chosen to prevent common mode currents on the cable shield. The suppression of common mode currents for each cable trap should provide an attenuation of at least 20 dB in order to provide an effective protection against an unwanted temperature increase and related effects such as MRI signal loss.^[@B35]^ It was shown that each trap used in this work complies with the requirement using a standard network analyzer. Moreover, interactions of the transducer and the cable with the electromagnetic field of the MRI were evaluated in detail. If common mode currents are present on the cable shield, the image homogeneity will be affected as shown by Seeber et al.,^[@B23]^ resulting in a decreased signal intensity. It was shown that the introduction of the cable and transducer did not affect the signal intensity. The maximum change was in the order of reported values of 2--6% by Seeber et al.,^[@B23]^ indicating a sufficient attenuation of common mode signals. Moreover, common mode signals on the cable shield take on characteristics of antennas and will influence the B~1~ field.^[@B35]^ It was shown in this work that the B~1~ field is not altered, indicating a correct attenuation of common mode signals. As the measurements at the test bench and inside the MRI showed a concurrent suppression of common mode signals, the cable and transducer were considered MR conditional.

In addition to the required MRI safety, the DUS device was evaluated regarding possible distortions due to MRI interferences. The results using the heart phantom showed no interaction between the MRI and the DUS signal and a high correlation between the generated motion of the heart phantom and DUS gating signal over a wide range of different heart rates for both evaluated field strengths. The DUS device showed a very high sensitivity where no heart cycle was missed at both field strength. Moreover, the DUS signal and MRI images showed no artifacts in the DUS or MRI signal, hence indicating a sufficient MRI compatibility for 1.5T and 3T. The variability of the detected heart motion was in the order of 5.5 ms. However, the detection is dependent on the movement of the heart, the correct detection by the algorithm, processing time and by the sampling rate of the system. As the sampling rate was 200 Hz, the variability of the generated gating signal will automatically vary about 5 ms. Hence, the added variability added by the DUS device was less than 1 ms and therewith negligible compared to the heart rate variability of the fetal heart, which is in the order of 25 ms.^[@B36]^

Besides the prerequisite of MRI compatibility, the DUS device should reliably detect the fetal heart movement. Hence, the developed system and algorithm was evaluated *in vivo* in healthy pregnant volunteers outside the MR environment, comparing DUS detected and manually selected heart cycles. In accordance with results of the heart phantom, the measurements showed a high correlation between detected heart cycles by the DUS device and the manually selected heart cycles. One of the main requirements for the DUS device is an accurate detection of the heart cycle with a low variability as a high variability in trigger time points leads to image blurring.^[@B20],[@B37]^ In this work, the measured heart rate variability is in the range of previously reported values of 16--25 ms^[@B38]^ indicating an accurate detection of each heart cycle.

As the DUS device showed sufficient MRI compatibility and functionality in terms of safety and accurate heart rate detection, it was used for fetal cardiac cine imaging at 1.5T and 3T MRI systems in a preliminary test. Images were acquired in four-chamber view as it is the most important view regarding a number of congenital heart diseases that have a change in ventricular size.^[@B39]^ Acquisition of cine images was successful at 1.5T and 3T and showed no motion artifacts related to incorrect gating. The contraction of the fetal ventricles was clearly visible without artifacts in each of the acquired heart phases, which is important for the evaluation of fetal morphology and diagnosis of e.g., hypoplastic left heart syndrome or tricuspid atresia.

The scope of this work was the development and evaluation of the DUS device in terms of MR compatibility and functionality. It was shown that the DUS device is not altered by the electromagnetic field of the MRI and that the device shows a sufficient MR compatibility in order to provide patient safety. As fetal cardiac MRI has the potential to become an important diagnostic tool for diagnosis of fetal congenital abnormalities in addition to fetal echocardiography,^[@B12],[@B13],[@B39]^ the ability to evaluate the fetal cardiac kinetics will become more important.

To overcome the current limitation of no available gating method for fetal cardiac MRI several methods were introduced in the past based on post-processing. One major innovation was the introduction of metric optimized gating, which is based on an iterative process to optimize the image metric until the correct heart rate or minimal motion blurring is found.^[@B14],[@B40]^ In addition, metric optimized gating was recently combined with compressed sensing and radial undersampling to overcome fetal body motion during acquisition.^[@B41]^ Other post-processing methods are also based on retrospective processing to detect motion and to correct for its effect.^[@B12],[@B13]^ Although post-processing techniques have the advantage of not utilizing additional hardware and are able to produce high-quality diagnostic images, post-processing times of up to 2 h for a single slice illustrate the current limitation of all such techniques for the implementation in clinical routine.^[@B40]^ Currently used post-processing methods are designed to reveal the fetal heart rate in order to correct for image blurring. One major advantage of a direct gating method is an immediate reconstruction, allowing adjustments of imaging planes and assessment of image quality during examination. Moreover, a direct gating signal allows the application of clinically used cardiac MRI sequences and methods, such as cine SSFP and phase contrast imaging for fetal cardiac MRI.

This work should provide the basis for future studies that have to investigate the feasibility of DUS gated fetal cardiac MRI in a larger cohort with a special focus on image quality and analysis of cardiac anatomical structures.

One limitation of the DUS device is that it cannot adjust for major fetal body motion. If the fetal heart moves out of the acoustic field of the DUS transducer, the DUS signal will be lost and no gating signal can be produced. However, the coverage of the acoustic field of the DUS transducer has a diameter of 6 cm and any motion within this range leads to a stable trigger signal. One possibility to adapt for major fetal motion could be the usage of multiple transducers or an increase of the acoustic field. Moreover, another limitation is that the DUS device was only validated in healthy fetuses outside the MR environment in order to verify the developed algorithm. The detection of one heart cycle could be influenced in cases of congenital heart diseases, such as complex malformations. Hence, the signal quality of the DUS device for cardiac gating needs further evaluation to ensure reliable gating signals for pathological conditions. Feasibility of the DUS device to perform dynamic fetal cardiac MRI and image quality have to be evaluated in future studies.

Conclusion
==========

In conclusion, the DUS device showed a sufficient MR compatibility for 1.5T and 3T and was validated successfully outside the MRI room and in a phantom study without being influenced by the electromagnetic field of the MRI and without introducing image artifacts. It was shown that an accurate gating can be provided in real time during MRI image acquisition using DUS, without extensive and time-consuming post-processing techniques. Preliminary results of a fetal cardiac MR examination at 1.5T and 3T revealed that the DUS device has the potential to realize dynamic fetal cardiac MRI. However, in future studies, this method has to be applied in a larger study group to confirm feasibility and to investigate the image quality and diagnostic potential.
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![(**A**) Used Doppler ultrasound (DUS) system with the ultrasound transducer (1) connected to the transmission line containing the cable traps, which are covered by a surrounding isolating sleeve (2). The ultrasound transducer is finally connected to the DUS device (3). The application of the DUS device to derive a fetal cardiac gating signal is shown schematically in (**B**). The transducer is placed above the fetal heart and is connected with the DUS electronic via a cable including cable traps to attenuate radiofrequency (RF) interferences. After signal acquisition, the signal processing algorithm is outlined schematically. The gating output is finally connected to the physiologic unit of the MRI.](mrms-17-308-g1){#F1}

![The setup and dimensions of the used biventricular heart phantom are shown in (**a**--**c**). An example of the measured Doppler ultrasound signal from the moving heart phantom mimicking fetal heart movement is shown in (**d**) with corresponding detected gating signals (BPM = 118).](mrms-17-308-g2){#F2}

![Shown are coronal B~1~ flip angle maps and axial gradient echo images at 1.5T (upper row) and at 3T (bottom row) for cases with transducer inside the scanner (dashed line) on top of the phantom in (**b**) and (**f**) and without transducer inside the magnetic resonance scanner in (**a**) and (**e**). No effects on B~1~ field homogeneity due to the cable or transducer are visible for 1.5T or for 3T as shown in the image difference in (**c**) and (**g**). No geometric distortions or signal loss due to common-mode currents were visible with the transducer inside the MRI using Gradient echo images for 1.5T (**d**) and for 3T (**h**).](mrms-17-308-g3){#F3}

![Shown are exemplary steady-state free precession (SSFP) images of the fetal cardiac phantom at 1.5T (upper row) and at 3T (bottom row). Images during mid-diastole are shown in (**a**) and in (**c**) with their corresponding projection over one whole cardiac cycle in (**b**) and (**d**).](mrms-17-308-g4){#F4}

![The results of the Doppler ultrasound (DUS) gating validation using the heart phantom during MRI acquisition for heart rates ranging from 75 to 200 BPM is shown in (**a**) and (**b**), for the *in vivo* validation outside of MRI in (**c**) and (**d**). The dashed lines of the Bland Altman plot in (**b**) and (**d**) represent the confidence interval of ±1.96 of the standard deviation.](mrms-17-308-g5){#F5}

![Exemplary the Doppler ultrasound (DUS) signal during MRI acquisition for one fetus at 1.5T. The dashed lines represent the detected gating time points of DUS device which are sent to the physiologic unit of the MRI scanner for gating.](mrms-17-308-g6){#F6}

![Preliminary fetal cardiac steady-state free precession (SSFP) cine images in four-chamber view for 1.5T (upper row) and 3T (bottom row). Gated images are shown in diastole in (**a**) and (**d**), for systole in (**b**) and (**e**). The corresponding projection over one cardiac cycle is shown in (**c**) and (**f**).](mrms-17-308-g7){#F7}

###### 

Results of cable trap attenuation

  Cable trap         1       2       3       4
  ------------------ ------- ------- ------- -------
  64 MHz (S21 dB)    48      50      47      45
  128 MHz (S21 dB)   42.42   47.18   39.15   26.22

The values shown in the table are the S21 measurement results in dB for each cable trap at 1.5T (64 MHz) and 128 MHz (3T) using a network analyzer and current probes. Each cable trap fulfilled the minimum requirement of 20 dB.

###### 

DUS gating results

                                       RR intervals   RR length (ms)   Difference in RR length (msec)   Variability (msec)   Sensitivity (%)
  -------------------- --------------- -------------- ---------------- -------------------------------- -------------------- -----------------
  1.5T                 Heart phantom   2924           408 ± 127        --                               0.1 ± 0.01           100
  DUS device           2924            404 ± 126      5.5 ± 4.5        6.4 ± 2.1                        100                  
  3T                   Heart phantom   2789           444 ± 147        --                               0.1 ± 0.01           100
  DUS device           2789            443 ± 147      5.6 ± 4.6        6.5 ± 2.8                        100                  
  Fetal verification   Heart cycle     1876           434 ± 32         --                               22.0 ± 7.6           100
  DUS device           1860            434 ± 31       0.01 ± 11        22.2 ± 7.1                       99.1                 

The values shown in the tables are the Doppler ultrasound (DUS) gating results for the phantom study at 1.5T and 3T and for the *in vivo* verification study outside the MRI room. RR, beat-to-beat.
